Pregnancy outcome in dairy and beef cattle after artificial insemination and treatment with seminal plasma or transforming growth factor beta-1.
Reduced capability of the uterus to support pregnancy in the absence of its interaction with secretions from male accessory glands has been demonstrated in rodents and to some extent in pigs. However, in cattle, the role of postmating inflammatory response on pregnancy success has not been studied. The current study examined the influence of uterine presensitization with seminal antigens at breeding on pregnancy outcome in cows. Lactating beef (n=1090) and dairy (n=800) cows received 0.5 mL seminal plasma (SP), 40 ng recombinant human transforming growth factor-beta1 (rhTGF-beta1), or 0.5 mL bovine serum albumin (BSA), or were left untreated before or at insemination. Semen was deposited into the anterior cervix using a second insemination gun. Pregnancy was diagnosed at 35 to 40 d postinsemination by transrectal ultrasonography or from records of calves born the subsequent calving season. Pregnancy rates in beef cows did not differ among treatments but differed among trials (69.8%, 52.5% vs. 40.3%; P<0.05). In trials where average pregnancy rates were below 50%, treatments with TGF-beta1 but not SP tended (P<0.07) to increase pregnancy rates in beef cows. In dairy cows, SP and TGF-beta1 improved pregnancy outcome by 10 percentage points, but these increments did not achieve statistical significance. In conclusion, this study did not find any conclusive evidence for the effect of TGF-beta1 or seminal plasma on pregnancy outcome in lactating dairy or beef cows but realized marginal improvements when pregnancy rates were below 50% (compromised fertility).
Odhiambo
J F
JF
Division of Animal and Nutritional Sciences, West Virginia University, P.O. Box 6108, Morgantown, WV 26506-6108, USA.
Poole
D H
DH
Hughes
L
L
Dejarnette
J M
JM
Inskeep
E K
EK
Dailey
R A
RA
D000818:Animals; D001947:Breeding / Q000379:methods*; D002417:Cattle; D005260:Female; D006801:Humans; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary*; D008297:Male; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000662:veterinary*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*; D012661:Semen; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology*
D011993:Recombinant Fusion Proteins; D053773:Transforming Growth Factor beta1